Viatris Inc. supplies high-quality medicines to approximately 1 billion patients around the world each year. The company has a global footprint, an extensive portfolio of medicines that is well-diversified across therapeutic areas, a one-of-a-kind gl…
Analysis
Bargain bin
Viatris Inc. falls in the bargain bin: the price is low relative to peers, but the business metrics give reason to pause.
The price is attractive. You pay 9.2× its owner earnings: the cash an owner could take out each year, which is in the historically attractive zone. At today's price, the market is assuming roughly -4% yearly growth; analysts expect 4%. The price, in other words, assumes less than the experts do.
The trajectory is moderate and the balance sheet is stretched. The company scores 8/20 on our value-creation score: creating some value.
What to watch: The financial cushion is thinner than comfortable. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Feb 202698
95
2026
All-time high
98
Feb 2026
All-time low
81
Mar 2026
Average rank
91
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
93
—
—
—
Price/Earnings
31
—
—
—
Price/Book
73
—
—
—
Dividend Yield
99
—
—
—
Value (overall)
100
—
—
—
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.